7.5 mg tirzepatide to units Tirzepatide conversion chart: every concentration,

Important safety considerations include: Separate fiber supplements from medications : Take fiber supplements at least 2 hours apart from oral medications to avoid potential interference with absorption Monitor for obstruction symptoms : Severe abdominal pain, inability to pass gas, or vomiting requires immediate medical evaluation, as FDA labels for GLP-1 medications include rare postmarketing reports of intestinal obstruction (ileus) [1] [2] Coordinate with healthcare providers : Patients with inflammatory bowel disease, diverticulitis history, or other gastrointestinal conditions need individualized fiber recommendations Adjust fluid intake appropriately : Follow medical guidance if you have conditions requiring fluid restriction Patients should contact their healthcare provider if gastrointestinal symptoms persist despite dietary modifications, worsen significantly, or include warning signs such as blood in stool, unintentional weight loss beyond expected therapeutic effects, or severe abdominal pain

This is something most guides completely ignore, but it matters enormously in practice

doi: 10.3389/fphar.2026.1789257 Received 16 January 2026 Revised 20 April 2026 Accepted 22 April 2026 Published 20 May 2026 Volume 17 - 2026 Edited by Cyril Ronco, Universit Cte d'Azur, France Reviewed by Finbarr P

Your insurance already covers Wegovy Use the NovoCare Savings Offer to pay $25 or less per month